Although this study failed to induce hepatocellular carcinoma due to short-term treatment, the correlation of Osr1 expression levels with cell proliferation and survival, in concurrence with the HFD and DEN treatment, was still worth investigating. Here, OSR1 is linked to hepatocellular carcinoma.